Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02177513Phase 1Completed
Phase 1, randomised, double-blind trial of cannabis (5 arms), sponsored by National Institute on Drug Abuse. Primary endpoints: Cannabis' pharmacodynamic effects, Cannabis' pharmacokinetic profiles and 2 more. Started Jun 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02177513.